搜索
Elanco Animal Health Inc
ELAN添加自选
23.650USD
-0.365-1.52%
收盘 05/08, 16:00（美东）报价延迟15分钟
11.81B总市值
亏损市盈率 TTM
关于 Elanco Animal Health Inc 公司
Elanco Animal Health Incorporated is an animal health company delivering products and services to prevent and treat disease in farm animals and pets. The Company's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). It has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The Company's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.
Elanco Animal Health Inc简介
公司代码ELAN
公司名称Elanco Animal Health Inc
上市日期Sep 20, 2018
CEOSimmons (Jeffrey N)
员工数量9000
证券类型Ordinary Share
年结日Sep 20
公司地址450 Elanco Circle
城市INDIANAPOLIS
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United States of America
邮编46221
电话18773526261
网址https://www.elanco.com/
公司代码ELAN
上市日期Sep 20, 2018
CEOSimmons (Jeffrey N)
Elanco Animal Health Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.25M
+27.46%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
229.43K
+10.35%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Chairman of the Board
Independent Chairman of the Board
170.34K
--
Mr. Timothy J. (Tim) Bettington
Mr. Timothy J. (Tim) Bettington
Executive Vice President - Corporate Strategy and Market Development
Executive Vice President - Corporate Strategy and Market Development
158.49K
+49.27%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
109.58K
--
Mr. Art A. Garcia, CPA
Mr. Art A. Garcia, CPA
Independent Director
Independent Director
91.28K
--
Dr. Deborah Turner Kochevar, Ph.D.
Dr. Deborah Turner Kochevar, Ph.D.
Independent Director
Independent Director
89.71K
--
Mr. Paul S. Herendeen
Mr. Paul S. Herendeen
Independent Director
Independent Director
84.81K
--
Ms. Shiv O'Neill
Ms. Shiv O'Neill
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
83.83K
+35.69%
Mr. James Meer
Mr. James Meer
Senior Vice President, Chief Accounting Officer
Senior Vice President, Chief Accounting Officer
71.18K
+12.12%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.25M
+27.46%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
229.43K
+10.35%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Chairman of the Board
Independent Chairman of the Board
170.34K
--
Mr. Timothy J. (Tim) Bettington
Mr. Timothy J. (Tim) Bettington
Executive Vice President - Corporate Strategy and Market Development
Executive Vice President - Corporate Strategy and Market Development
158.49K
+49.27%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
109.58K
--
Mr. Art A. Garcia, CPA
Mr. Art A. Garcia, CPA
Independent Director
Independent Director
91.28K
--
收入明细
单位: USD更新时间: 4月6日 周一
单位: USD更新时间: 4月6日 周一
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
业务USD
名称
营收
占比
Farm Animal
2.36B
50.10%
Pet Health
2.30B
48.78%
Contract Manufacturing
53.00M
1.12%
地区USD
名称
营收
占比
International
2.48B
52.62%
United States
2.23B
47.38%
业务
地区
业务USD
名称
营收
占比
Farm Animal
2.36B
50.10%
Pet Health
2.30B
48.78%
Contract Manufacturing
53.00M
1.12%
股东统计
更新时间: 11 小时前
更新时间: 11 小时前
持股股东
股东类型
持股股东
持股股东
占比
Dodge & Cox
15.83%
PRIMECAP Management Company
9.25%
BlackRock Institutional Trust Company, N.A.
8.17%
Fidelity Management & Research Company LLC
7.82%
T. Rowe Price Investment Management, Inc.
7.05%
其他
51.87%
持股股东
持股股东
占比
Dodge & Cox
15.83%
PRIMECAP Management Company
9.25%
BlackRock Institutional Trust Company, N.A.
8.17%
Fidelity Management & Research Company LLC
7.82%
T. Rowe Price Investment Management, Inc.
7.05%
其他
51.87%
股东类型
持股股东
占比
Investment Advisor
74.55%
Investment Advisor/Hedge Fund
36.56%
Hedge Fund
4.40%
Research Firm
1.99%
Individual Investor
1.29%
Pension Fund
1.13%
Bank and Trust
0.67%
Sovereign Wealth Fund
0.29%
Family Office
0.12%
机构持股
更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q1
950
549.30M
109.98%
-60.07M
2025Q4
852
577.24M
120.43%
+30.91K
2025Q3
891
577.57M
121.95%
+32.95M
2025Q2
878
543.55M
113.98%
+36.20M
2025Q1
945
503.90M
116.31%
-73.53M
2024Q4
964
498.16M
117.36%
+7.74M
2024Q3
970
490.73M
118.81%
+19.54K
2024Q2
1004
491.01M
118.24%
+1.27M
2024Q1
1021
489.85M
119.72%
-100.34M
2023Q4
1018
489.74M
120.73%
-3.72M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Dodge & Cox
79.08M
15.91%
-3.68M
-4.44%
Dec 31, 2025
PRIMECAP Management Company
46.21M
9.3%
-3.74M
-7.49%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
40.81M
8.21%
+388.49K
+0.96%
Dec 31, 2025
Fidelity Management & Research Company LLC
39.05M
7.86%
-11.69M
-23.03%
Dec 31, 2025
T. Rowe Price Investment Management, Inc.
35.23M
7.09%
+3.72M
+11.80%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
25.08M
5.05%
+373.87K
+1.51%
Dec 31, 2025
State Street Investment Management (US)
15.05M
3.03%
-195.25K
-1.28%
Dec 31, 2025
Fidelity Institutional Asset Management
12.16M
2.45%
-67.80K
-0.55%
Dec 31, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares U.S. Pharmaceuticals ETF
4.06%
Adaptiv Select ETF
3.38%
State Street SPDR S&P Pharmaceuticals ETF
3.15%
Brandes US Small-Mid Cap Value ETF
3.14%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
2.84%
VanEck Agribusiness ETF
2.3%
First Trust Health Care Alphadex Fund
1.92%
Federated Hermes MDT Large Cap Value ETF
1.9%
First Trust NASDAQ Pharmaceuticals ETF
1.33%
Invesco S&P MidCap 400 Pure Value ETF
1.22%
查看更多
iShares U.S. Pharmaceuticals ETF
占比4.06%
Adaptiv Select ETF
占比3.38%
State Street SPDR S&P Pharmaceuticals ETF
占比3.15%
Brandes US Small-Mid Cap Value ETF
占比3.14%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
占比2.84%
VanEck Agribusiness ETF
占比2.3%
First Trust Health Care Alphadex Fund
占比1.92%
Federated Hermes MDT Large Cap Value ETF
占比1.9%
First Trust NASDAQ Pharmaceuticals ETF
占比1.33%
Invesco S&P MidCap 400 Pure Value ETF
占比1.22%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
